Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jane Lebkowski


  • Chief Scientific Officer at Asterias Biotherapeutics Inc. (AST), 2017-06-07
  • Other at Geron Corp (GERN), 2012-02-14
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AST $6.00 4,912 Officer 476 2015-09-15 Filing
GERN $4.28 25,262 Officer 568,154 2011-06-14 Filing
GERN $4.47 2,975 Officer 593,416 2011-05-24 Filing
GERN $5.43 10,617 Officer 196,891 2010-06-02 Filing
GERN $5.11 2,336 Officer 207,508 2010-05-24 Filing